Tradestie Institutional Equity Comparison Engine

NTLA vs DNTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DNTH Overall Edge

DNTH Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dianthus Therapeutics, Inc. Common Stock (DNTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus DNTH at N/M Forward P/E and -8683.9% operating margin (+205.6% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against DNTH sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NTLA N/M vs DNTH N/M Fwd P/E
Growth & Margin Winner DNTH
Op Margin -826.0% vs -8683.9% ยท YoY -48.0% vs +205.6%
Momentum & Technical Winner DNTH
1Y +15.3% vs +149.5% ยท 52W Pos 20% vs 65%
Options & Structure Winner DNTH
BREAKDOWN (78th %ile IV) vs CONSOLIDATION (7th %ile IV)
NTLA NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap $1.5B
1M Return -12.43%
1Y Return +15.34%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 59.0 Mom 60.0
DNTH NASDAQ
Dianthus Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$88.58
-3.52% 1D
Market Cap $5.2B
1M Return +22.87%
1Y Return +149.51%
Forward P/E N/M
Unified AI Score
34.1 / 100 SELL
Tech 8.0 Fund 43.0 Flow 68.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NTLA +15.34% DNTH +149.51% Spread: +134.17 pp (DNTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NTLA Revenue DNTH Revenue NTLA Op. Margin DNTH Op. Margin Margin Edge
FY2018 $30M N/A -298.6% N/A NTLA
FY2019 $40M N/A -246.8% N/A NTLA
FY2020 $60M N/A -235.5% N/A NTLA
FY2021 $30M N/A -810.4% N/A NTLA
FY2022 $50M N/A -879.0% N/A NTLA
FY2023 $40M $0M -1420.5% -1704.7% NTLA
FY2024 $60M $10M -923.1% -1633.7% NTLA
FY2025 $70M $0M -651.7% -8739.3% NTLA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NTLA (2) vs DNTH (5)
Institutional Metric NTLA DNTH Criterion Row Winner
Market Capitalization Scale $1.5B $5.2B Larger Scale DNTH
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -48.0% +205.6% Higher Growth DNTH
Operating Margin (TTM) Profitability -826.0% -8683.9% Higher Margin NTLA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -62.6% -22.6% Higher ROE DNTH
52-Week Range Position Momentum 20% ($8โ€“$18) 65% ($34โ€“$118) Stronger Trend DNTH
Beta / 30D Volatility Risk Regime 2.30ฮฒ ยท 87% Vol 1.03ฮฒ ยท 41% Vol Lower Realized Risk DNTH
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 34.1 / 100 (SELL) Higher Composite NTLA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NTLA vs DNTH Buy Guide
NTLA BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 78th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live NTLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DNTH CONSOLIDATION
149d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live DNTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NTLA nor DNTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.